Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_50e1e10db0639aaae88caa1d4decb83c |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2035-124 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2510-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-30756 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-3872 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0663 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0775 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02 |
filingDate |
2015-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_076dd0cb547a8d8e2b92947bc4f57b2d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba57a6ba777914a8c0aa544e044abd0e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b6e8c3c0e0ada82aab0a1733a4cbf43 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6fcabf9bcb997dd10e0c8d83b0776686 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd774c86fdb761380339eb3da9f58ffd |
publicationDate |
2015-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2015128633-A |
titleOfInvention |
Use of mesenchymal stem cells for the preparation of pharmaceutical compositions for joint repair in animals |
abstract |
A method for regenerating cartilage tissue in a joint including a meniscal tissue by repairing the joint and / or stabilizing the joint by administering mesenchymal stem cells to the joint. Use of an allogeneic mesenchymal stem cell and a pharmacologically acceptable carrier for the preparation of a pharmaceutical composition for repairing an animal joint comprising deforming the animal's deformable joint at a site damaged by half-moon injury Of allogeneic mesenchymal stem cells and a pharmacologically acceptable carrier for the preparation of a pharmaceutical composition for the treatment of diseases. For the preparation of a pharmaceutical composition for stimulating the differentiation of mesenchymal stem cells into meniscal tissue or the production of meniscal tissue in order to protect the cartilage of the joint at the site of meniscal injury in the animal, to repair the meniscal tissue in the joint Use of allogeneic mesenchymal stem cells for Use of allogeneic mesenchymal stem cells for the preparation of a pharmaceutical composition for reducing joint pain in animals. [Selection figure] None |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101720329-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016216487-A |
priorityDate |
2000-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |